More fundamental understanding of cell growth regulation will provide novel approaches for detecting, preventing, and treating different cancers.
of cell growth regulation is likely to provide novel approaches to detection, prevention, and treatment for a variety of cancers. The development and use of tumor markers should relate directly to these advances. Rather than undertaking an exhaustive review of cancer markers, the following perspective is based on a few selected reports. Studies of epithelial ovarian cancer and of breast cancer have provided several particularly good examples of the potential interaction between tumor markers and the management of disease. The multiple tumor nodules that stud the peritoneal surface have been assumed to be metastases from an ovarian primary tumor. Some two decades ago, however, Woodruff and Julian at Johns Hopkins suggested that many of these deposits were, in fact, independent primaries and that ovarian cancer was a multifocal disease (1) . Should this be the case, screening for early-stage disease would not be practical because there would not be an interval during which the cancer was limited to the ovary. With the development of contemporary molecular technology, it has finally been possible to determine whether ovarian cancer is a unifocal clonal disease or multifocal in origin. Tissue specimens have been obtained from 17 cases of ovarian cancer, sampling putative primary tumors and 2-15 apparent metastases. Clonality was analyzed by three techniques: measurement of heterozygosity at different loci, p53 mutations, and X chromosome inactivation. In 15 of 17 cases the ovarian cancers proved to be clonal (2 
